Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.rjbiotech.com | |
Market Cap | 3.93 Cr. | |
Enterprise Value(EV) | 54.56 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.28 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-03 |
Industry PE | - | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | Trailing Twelve Months Ending 2022-03 | |
Price to Book Value | Calculated using Price: 4.15 | |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.95 Cr. | 9,467,600 Shares |
FaceValue | 10 | |
About RJ Bio-Tech Ltd. | ||
R J Biotech was incorporated in the year 2005 in India. R J Biotech has its well-established and well-equipped Research, production, processing, QCL and Biotechnology facilities at various locations. The Research Stations are located at Aurangabad (MH) and Hyderabad (AP) backed by vast experienced scientists and breeders to make R & D foundation strong on which the Seeds Edifice will rest. The company has tied up with renowned companies for technology collaboration for its various crops. After three years of inhouse intensive Research, the products were commercially launched in 2008 and within a span of three years, the company is operating in ten states. |
1 Day |
|
|
1 Week |
|
-4.82% |
1 Month |
|
-4.82% |
3 Month |
|
-9.39% |
6 Month |
|
+8.92% |
1 Year |
|
-50.65% |
2 Year |
|
-33.28% |
5 Year |
|
-83.06% |
10 Year |
|
-88.58% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 18.15 | 7.03 | 9.91 | -88.93 | ||||||
Return on Capital Employed (%) | 14.47 | 10.86 | 11.73 | -25.86 | -51.57 | -32.76 | -19.75 | -218.35 | ||
Return on Assets (%) | 5.83 | 2.46 | 3.76 | -27.96 | -50.28 | -36.69 | -15.63 | -100.28 | -104.09 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 14 | 22 | 24 | 26 | 11 | -10 | -21 | -26 | -41 | -50 | |
Non Curr. Liab. | 4 | 3 | 3 | 1 | 2 | 6 | 6 | 6 | 4 | 4 | |
Curr. Liab. | 22 | 32 | 34 | 33 | 34 | 39 | 43 | 45 | 43 | 48 | |
Minority Int. | |||||||||||
Equity & Liab. | 41 | 58 | 61 | 60 | 48 | 35 | 28 | 25 | 6 | 2 | |
Non Curr. Assets | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | |
Curr. Assets | 35 | 52 | 56 | 55 | 44 | 32 | 24 | 22 | 4 | 0 | |
Misc. Exp. not W/O | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |||
Total Assets | 41 | 58 | 61 | 60 | 48 | 35 | 28 | 25 | 6 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. TTM | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 29 | 32 | 36 | 36 | 16 | 9 | 10 | 13 | 16 | 14 | |
Other Income | 0 | 0 | 0 | 1 | |||||||
Total Income | 29 | 32 | 36 | 36 | 16 | 9 | 10 | 13 | 16 | 15 | |
Total Expenditure | -23 | -26 | -30 | -30 | -27 | -17 | -17 | -17 | -28 | -13 | |
PBIDT | 6 | 6 | 6 | 6 | -11 | -8 | -7 | -3 | -13 | 2 | |
Interest | -3 | -4 | -3 | -3 | -4 | -4 | -4 | -1 | -6 | ||
Depreciation | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | |||||||||
Exceptional Items | 0 | -9 | 0 | -3 | 0 | ||||||
PAT | 3 | 1 | 2 | 2 | -15 | -21 | -12 | -4 | -16 | -4 | |
Adjusted EPS | 3 | 2 | 2 | 2 | -16 | -22 | -12 | -4 | -17 | -4 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 4 | -5 | 2 | 6 | 0 | -3 | 1 | 1 | 2 | -5 | |
Cash Fr. Inv. | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | 0 | ||
Cash Fr. Finan. | -3 | 8 | -1 | -5 | 1 | 3 | 0 | 0 | -2 | 5 | |
Net Change | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tue, 15 Nov 2022
Standalone Financial Results September 30 2022 Standalone Financial Results September 30 2022 |
Fri, 23 Sep 2022
Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP) Pursuant to an order dated 20.09.2022 of NCLT Bench Mumbai CIRP proceedings has been initiated and Mr. Anurag Kumar Sinha has been appointed as an IRP. |
Tue, 30 Aug 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015) R J Bio-Tech Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here |
Fri, 01 Dec 2023 |
|
|
|
|
|